Shuttle Pharmaceuticals Holdings, Inc. (SHPH) — S-1/A Filings
All S-1/A filings from Shuttle Pharmaceuticals Holdings, Inc.. Browse 3 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (3)
-
Shuttle Pharma Pivots to AI Drug Discovery, Discontinues Clinical Trials
— Dec 11, 2025 Risk: high
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has undergone a significant strategic pivot, discontinuing its Ropidoxuridine clinical trials and acquiring substa -
Shuttle Pharmaceuticals Files S-1/A Amendment
— Mar 5, 2025 Risk: medium
Shuttle Pharmaceuticals Holdings, Inc. filed an S-1/A amendment on March 5, 2025, for its registration statement. The company, incorporated in Delaware, is in t -
Shuttle Pharmaceuticals Files S-1/A Update
— Oct 18, 2024 Risk: medium
Shuttle Pharmaceuticals Holdings, Inc. filed an S-1/A on October 18, 2024, detailing its financial status and business operations. The company, located in Gaith
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX